OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Interfering with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy
Patrick Müller, Hannah Maus, Stefan Hammerschmidt, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 4, pp. 635-665
Closed Access | Times Cited: 14
Patrick Müller, Hannah Maus, Stefan Hammerschmidt, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 4, pp. 635-665
Closed Access | Times Cited: 14
Showing 14 citing articles:
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors
Santo Previti, Roberta Ettari, Elsa Calcaterra, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115021-115021
Open Access | Times Cited: 19
Santo Previti, Roberta Ettari, Elsa Calcaterra, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115021-115021
Open Access | Times Cited: 19
Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors—A Comprehensive Reactivity and Selectivity Study
Patrick Müller, Mergim Meta, J. Laurenz Meidner, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7226-7226
Open Access | Times Cited: 8
Patrick Müller, Mergim Meta, J. Laurenz Meidner, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7226-7226
Open Access | Times Cited: 8
Coordination chemistry suggests that independently observed benefits of metformin and Zn2+ against COVID-19 are not independent
Thomas D. Lockwood
BioMetals (2024) Vol. 37, Iss. 4, pp. 983-1022
Open Access | Times Cited: 2
Thomas D. Lockwood
BioMetals (2024) Vol. 37, Iss. 4, pp. 983-1022
Open Access | Times Cited: 2
Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin
Anna Ohradanova‐Repic, Rostislav Škrabana, Laura Gebetsberger, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Anna Ohradanova‐Repic, Rostislav Škrabana, Laura Gebetsberger, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Causes and Consequences of Coronavirus Spike Protein Variability
Fabian Zech, Christoph Jung, Timo Jacob, et al.
(2024)
Open Access | Times Cited: 1
Fabian Zech, Christoph Jung, Timo Jacob, et al.
(2024)
Open Access | Times Cited: 1
Identification of Dual Inhibitors Targeting Main Protease (Mpro) and Cathepsin L as Potential Anti-SARS-CoV-2 Agents
Santo Previti, Roberta Ettari, Elsa Calcaterra, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 5, pp. 602-609
Closed Access | Times Cited: 1
Santo Previti, Roberta Ettari, Elsa Calcaterra, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 5, pp. 602-609
Closed Access | Times Cited: 1
Establishment, optimization and validation of a fluorescence polarization-based high-throughput screening assay targeting cathepsin L inhibitors
Wenwen Zhou, Baoqing You, Xiaomeng Zhao, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 3, pp. 100153-100153
Open Access | Times Cited: 1
Wenwen Zhou, Baoqing You, Xiaomeng Zhao, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 3, pp. 100153-100153
Open Access | Times Cited: 1
Next Generation of Fluorometric Protease Assays: 7‐Nitrobenz‐2‐oxa‐1,3‐diazol‐4‐yl‐amides (NBD‐Amides) as Class‐Spanning Protease Substrates
Hannah Maus, Patrick Müller, Mergim Meta, et al.
Chemistry - A European Journal (2023) Vol. 29, Iss. 50
Open Access | Times Cited: 2
Hannah Maus, Patrick Müller, Mergim Meta, et al.
Chemistry - A European Journal (2023) Vol. 29, Iss. 50
Open Access | Times Cited: 2
Causes and Consequences of Coronavirus Spike Protein Variability
Fabian Zech, Christoph Jung, Timo Jacob, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 177-177
Open Access
Fabian Zech, Christoph Jung, Timo Jacob, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 177-177
Open Access
COVID-19 story: Entry and immune response
Ali Mohammed Ashraf, Marwan Y. Al-Maqtoofi, Ahmed A. Burghal
Vacunas (2024) Vol. 26, Iss. 1, pp. 100380-100380
Closed Access
Ali Mohammed Ashraf, Marwan Y. Al-Maqtoofi, Ahmed A. Burghal
Vacunas (2024) Vol. 26, Iss. 1, pp. 100380-100380
Closed Access
Novel inhibitors and activity-based probes targeting serine proteases
Timothy Ferguson, James Reihill, Lorraine Martin, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 3
Timothy Ferguson, James Reihill, Lorraine Martin, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 3
Entry Inhibitors of RNA Viruses
Edeildo Ferreira da Silva‐Júnior
Current Medicinal Chemistry (2022) Vol. 29, Iss. 4, pp. 609-611
Closed Access
Edeildo Ferreira da Silva‐Júnior
Current Medicinal Chemistry (2022) Vol. 29, Iss. 4, pp. 609-611
Closed Access
Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by the N-terminal peptide of lactoferrin
Anna Ohradanova‐Repic, Laura Gebetsberger, Gábor Tajti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Anna Ohradanova‐Repic, Laura Gebetsberger, Gábor Tajti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
